CBIH plans expanded research into endocannabinoid science and personalized medicine
CBIH•Cannabis Bioscience International Holdings plans research linking endocannabinoid biology with precision medicine, aiming to develop intellectual property with potential biomedical applications. It also intends to explore research partnerships and licensing agreements in anticipation of proposed federal marijuana rescheduling.
1. Planned research
Cannabis Bioscience International Holdings plans studies of cannabinoid interactions with cellular pathways involved in complex diseases, with the goal of supporting potentially patentable technologies. The company intends to explore research partnerships and licensing agreements ahead of proposed federal rescheduling of marijuana from Schedule I to Schedule III, targeting future commercialization through medical, pharmaceutical and biotechnology organizations.
